Cinryze TM C1 inhibitor

Related by string. * : ViroPharma commercializes Cinryze . ViroPharma commercializes Cinryze TM . manufacture Cinryze TM / Tm . TMD . TMs : FinancialWire tm website . TM EA SPORTS . Contact FinancialWire tm / c1 . C1s . C1S : C1 C2 . Toughbook C1 . endogenous C1 inhibitor / Inhibitor . Inhibitors . inhibitors : proton pump inhibitors . proton pump inhibitors PPIs . small molecule inhibitor * *

Related by context. Frequent words. (Click for all words.) 55 DAVANAT R 55 humanized monoclonal antibody 54 RDEA# 53 investigational drug 53 immunotherapeutic 53 oritavancin 52 Phase 2a clinical 51 MGCD# [001] 51 hematological malignancies 50 RNAi therapeutic 50 recombinant human 50 Marqibo 50 ONCONASE 50 Phase III clinical 50 Topical Interferon Alpha 2b 50 Homspera 50 human monoclonal antibody 49 IND enabling 49 preclinical 49 Phase IIa clinical 49 Marketing Authorization Application 48 ATryn R 48 New Drug IND 48 oncology indications 48 tamibarotene 48 Phase III clinical trials 48 Phase 2b clinical 48 cutaneous T cell 48 IDX# 48 Phase Ib 48 intravenous formulation 47 Marketing Authorization Application MAA 47 investigational 47 MOR# 47 Phase IIb clinical 47 Biologics License Application 47 vilazodone 47 NGX# 46 Rhucin 46 CORLUX 46 cytomegalovirus 46 arimoclomol 46 clofarabine 46 Orphan Drug 46 Alpharadin 46 investigational oral 46 voclosporin 46 oral formulation 46 Phase 2a 46 Biologics License Application BLA 46 Phase 2b study 45 Phase IIa 45 Iluvien 45 Phase IIa trial 45 preclinical studies 45 pivotal Phase III 45 investigational compound 45 PRX # 44 carfilzomib 44 linaclotide 44 phase IIb 44 AP# [003] 44 GATTEX 44 Phase 2a trial 44 Phase 2b trial 44 Bronchitol 44 orphan drug 43 Cimzia ® 43 New Drug Application 43 bavituximab 43 ofatumumab 43 BYDUREON 43 bacteriophage 43 Orphan Drug designation 43 dose escalation trial 43 pivotal Phase 42 Fodosine TM 42 sBLA 42 Phase 1b 42 CBLB# 42 Phase III pivotal 42 Phase 2b 42 AEOL # 42 confirmatory Phase 3 42 Investigational 42 clinical trial 42 Phase III trials 41 NDA submission 41 dose escalation study 41 Orphan Drug Designation 41 INDs 41 initiate Phase 40 randomized Phase 40 CF# [002] 40 multiple ascending dose 40 Phase IIb 40 TLR9 39 sNDA 39 Phase IIb trial 39 IND 38 Phase III

Back to home page